Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART II-Surgical Evaluation and Treatment
- PMID: 34384236
- DOI: 10.1097/JU.0000000000002184
Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART II-Surgical Evaluation and Treatment
Erratum in
-
Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline PART II-Surgical Evaluation and Treatment. Erratum.J Urol. 2022 Mar;207(3):743. doi: 10.1097/JU.0000000000002388. Epub 2022 Mar 1. J Urol. 2022. PMID: 35135337 No abstract available.
-
Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I-Initial Work-up and Medical Management. Erratum.J Urol. 2022 Oct;208(4):939. doi: 10.1097/JU.0000000000002911. Epub 2022 Sep 9. J Urol. 2022. PMID: 36082556 No abstract available.
-
MP05-20 ISOPSA Substantially Reduces Unneeded Biopsies in a Real-World Office Setting. Erratum.J Urol. 2022 Mar;207(3):743. doi: 10.1097/JU.0000000000002436. Epub 2022 Mar 1. J Urol. 2022. PMID: 37052342 No abstract available.
Abstract
Purpose: Surgical therapies for symptomatic bladder outlet obstruction (BOO) due to benign prostatic hyperplasia (BPH) are many, and vary from minimally invasive office based to high-cost operative approaches. This Guideline presents effective evidence-based surgical management of male lower urinary tract symptoms secondary/attributed to BPH (LUTS/BPH). See accompanying algorithm for a detailed summary of procedures (figure[Figure: see text]).
Materials/methods: The Minnesota Evidence Review Team searched Ovid MEDLINE, Embase, Cochrane Library, and AHRQ databases to identify eligible studies published between January 2007 and September 2020, which includes the initial publication (2018) and amendments (2019, 2020). The Team also reviewed articles identified by Guideline Panel Members. When sufficient evidence existed, the body of evidence was assigned a strength rating of A (high), B (moderate), or C (low) for support of Strong, Moderate, or Conditional Recommendations. In the absence of sufficient evidence, information is provided as Clinical Principles and Expert Opinions (table[Table: see text]).
Results: Twenty-four guideline statements pertinent to pre-operative and surgical management were developed. Appropriate levels of evidence and supporting text were created to direct urologic providers towards suitable and safe operative interventions for individual patient characteristics. A re-treatment section was created to direct attention to longevity and outcomes with individual approaches to help guide patient counselling and therapeutic decisions.
Conclusion: Pre-operative and surgical management of BPH requires attention to individual patient characteristics and procedural risk. Clinicians should adhere to recommendations and familiarize themselves with criteria that yields the highest likelihood of surgical success when choosing a particular approach for a particular patient.
Keywords: BPH; HoLEP; LUTS; MIST; PUL; PVP; Prostate surgery; TUIP; TUMT; TURP; TUVP; ThuLEP; aquablation; open prostatectomy; robotic assisted simple prostatectomy; simple prostatectomy; water vapor thermal therapy.
Similar articles
-
Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I-Initial Work-up and Medical Management.J Urol. 2021 Oct;206(4):806-817. doi: 10.1097/JU.0000000000002183. Epub 2021 Aug 13. J Urol. 2021. PMID: 34384237
-
Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline Amendment 2019.J Urol. 2019 Sep;202(3):592-598. doi: 10.1097/JU.0000000000000319. Epub 2019 Aug 8. J Urol. 2019. PMID: 31059668
-
Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia (BPH): AUA Guideline Amendment 2023.J Urol. 2024 Jan;211(1):11-19. doi: 10.1097/JU.0000000000003698. Epub 2023 Sep 14. J Urol. 2024. PMID: 37706750
-
Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis.Cochrane Database Syst Rev. 2021 Jul 15;7(7):CD013656. doi: 10.1002/14651858.CD013656.pub2. Cochrane Database Syst Rev. 2021. PMID: 34693990 Free PMC article. Review.
-
Robotic assisted simple prostatectomy: recent advances.Curr Opin Urol. 2018 May;28(3):309-314. doi: 10.1097/MOU.0000000000000499. Curr Opin Urol. 2018. PMID: 29528970 Review.
Cited by
-
Holmium laser enucleation of the prostate: Modified urethral mucosa pre-dissected technique versus traditional three-lobe technique-A retrospective study.Lasers Med Sci. 2024 Nov 15;39(1):278. doi: 10.1007/s10103-024-04224-7. Lasers Med Sci. 2024. PMID: 39542933
-
Search trends in the treatment for benign prostatic hyperplasia: A twenty-year analysis.Asian J Urol. 2024 Oct;11(4):586-590. doi: 10.1016/j.ajur.2023.08.009. Epub 2023 Dec 9. Asian J Urol. 2024. PMID: 39533993 Free PMC article.
-
Current era HOLEP with MOSES 2.0 technology compared to the gold standard TURP.World J Urol. 2024 Nov 8;42(1):633. doi: 10.1007/s00345-024-05309-2. World J Urol. 2024. PMID: 39514127
-
Streamlined surgical approach for coexistent urethral stricture and benign prostatic enlargement: feasibility, safety and patency results.World J Urol. 2024 Oct 25;42(1):594. doi: 10.1007/s00345-024-05306-5. World J Urol. 2024. PMID: 39455449
-
Does sheath size matter: benchtop comparison of flow and pressure across variety of continuous flow endoscopes.World J Urol. 2024 Oct 10;42(1):573. doi: 10.1007/s00345-024-05270-0. World J Urol. 2024. PMID: 39390086
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
